FDA Adverse Event Injury Summary report: N

GORE-TEX® STRETCH VASCULAR GRAFT

MDR report key: 5093115 · Received September 21, 2015

Report

Report Number
2017233-2015-00635
Event Type
Injury
Date Received
September 21, 2015
Date of Event
July 29, 2010
Report Date
September 7, 2015
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
DSY
PMA / PMN Number
K903931
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SHEMESH D, GOLDIN I, HIJAZI J. A PROSPECTIVE RANDOMIZED STUDY OF HEPARIN-BONDED GRAFT (PROPATEN) VERSUS STANDARD GRAFT IN PROSTHETIC ARTERIOVENOUS ACCESS. J VASC SURG 2015;62:115-22. LOT: 7240430 (B)(4). (B)(4): MEDICATIONS: SIMVASTATIN, ASA, PLAVIX. A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE VERIFIED THAT THE LOT MET ALL PRE-RELEASE SPECIFICATIONS. THE DEVICE REMAINED IMPLANTED; CONSEQUENTLY, A DIRECT PRODUCT ANALYSIS WAS NOT POSSIBLE.

Description of Event or Problem · 1

IN THE MEDICAL LITERATURE, AN ARTICLE, "A PROSPECTIVE RANDOMIZED STUDY OF HEPARIN-BONDED GRAFT (PROPATEN) VERSUS STANDARD GRAFT IN PROSTHETIC ARTERIOVENOUS ACCESS." WAS REVIEWED. PATIENTS WITH END-STAGE RENAL FAILURE REQUIRING A PROSTHETIC ACCESS WERE RANDOMIZED TO RECEIVE EITHER A STANDARD EXPANDED POLYTETRAFLUROETHYLENE (EPTFE) GRAFT OR A HEPARIN-BONDED EPTFE GRAFT. PATIENTS WERE ENROLLED FROM JUNE 2007 UNTIL NOVEMBER 2011 AND WERE FOLLOWED UP UNTIL JULY 2013, WHEN THE STUDY CONCLUDED. THE PERFORMANCE OF GORE PROPATEN VASCULAR GRAFTS IN RESISTING THROMBOSIS, DECREASING EARLY FAILURE AND POSSIBLY PROLONGING PATENCY WAS ASSESSED. ON (B)(6) 2010, A PATIENT WAS IMPLANTED WITH A GORE-TEX STRETCH VASCULAR GRAFT FOR ARTERIOVENOUS ACCESS FROM THE BRACHIAL ARTERY TO THE BASILIC VEIN IN THE LEFT ARM. IT WAS REPORTED TO GORE THAT ON (B)(6) 2010, THE PATIENT PRESENTED WITH ARTERIAL STEAL SYNDROME. A REINTERVENTION PROCEDURE WAS PERFORMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
623966 GORE-TEX® STRETCH VASCULAR GRAFT PROSTHESIS, VASCULAR GRAFT DSY W.L. GORE & ASSOCIATES 7240430

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention